Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr

Detalhes bibliográficos
Autor(a) principal: Fedrigo, Carlos Alexandre
Data de Publicação: 2011
Outros Autores: Grivicich, Ivana, Schunemann, Daniel Pretto, Chemale, Ivan de Mello, Ferreira, Daiane Nicoli Silvello dos Santos, Jacovas, Thais, Boschetti, Patryck Stangl, Jotz, Geraldo Pereira, Braga Filho, Aroldo, Rocha, Adriana Brondani da
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/111830
Resumo: Background: Radiation therapy is routinely prescribed for high-grade malignant gliomas. However, the efficacy of this therapeutic modality is often limited by the occurrence of radioresistance, reflected as a diminished susceptibility of the irradiated cells to undergo cell death. Thus, cells have evolved an elegant system in response to ionizing radiation induced DNA damage, where p53, Hsp70 and/or EGFr may play an important role in the process. In the present study, we investigated whether the content of p53, Hsp70 and EGFr are associated to glioblastoma (GBM) cell radioresistance. Methods: Spheroids from U-87MG and MO59J cell lines as well as spheroids derived from primary culture of tumor tissue of one GBM patient (UGBM1) were irradiated (5, 10 and 20 Gy), their relative radioresistance were established and the p53, Hsp70 and EGFr contents were immunohistochemically determined. Moreover, we investigated whether EGFr-phospho-Akt and EGFr-MEK-ERK pathways can induce GBM radioresistance using inhibitors of activation of ERK (PD098059) and Akt (wortmannin). Results: At 5 Gy irradiation UGBM1 and U-87MG spheroids showed growth inhibition whereas the MO59J spheroid was relatively radioresistant. Overall, no significant changes in p53 and Hsp70 expression were found following 5 Gy irradiation treatment in all spheroids studied. The only difference observed in Hsp70 content was the periphery distribution in MO59J spheroids. However, 5 Gy treatment induced a significant increase on the EGFr levels in MO59J spheroids. Furthermore, treatment with inhibitors of activation of ERK (PD098059) and Akt (wortmannin) leads to radiosensitization of MO59J spheroids. Conclusions: These results indicate that the PI3K-Akt and MEK-ERK pathways triggered by EGFr confer GBM radioresistance.
id UFRGS-2_dd875113b2f95d9cbbe6f2851636a83a
oai_identifier_str oai:www.lume.ufrgs.br:10183/111830
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Fedrigo, Carlos AlexandreGrivicich, IvanaSchunemann, Daniel PrettoChemale, Ivan de MelloFerreira, Daiane Nicoli Silvello dos SantosJacovas, ThaisBoschetti, Patryck StanglJotz, Geraldo PereiraBraga Filho, AroldoRocha, Adriana Brondani da2015-03-07T01:57:11Z20111748-717Xhttp://hdl.handle.net/10183/111830000953426Background: Radiation therapy is routinely prescribed for high-grade malignant gliomas. However, the efficacy of this therapeutic modality is often limited by the occurrence of radioresistance, reflected as a diminished susceptibility of the irradiated cells to undergo cell death. Thus, cells have evolved an elegant system in response to ionizing radiation induced DNA damage, where p53, Hsp70 and/or EGFr may play an important role in the process. In the present study, we investigated whether the content of p53, Hsp70 and EGFr are associated to glioblastoma (GBM) cell radioresistance. Methods: Spheroids from U-87MG and MO59J cell lines as well as spheroids derived from primary culture of tumor tissue of one GBM patient (UGBM1) were irradiated (5, 10 and 20 Gy), their relative radioresistance were established and the p53, Hsp70 and EGFr contents were immunohistochemically determined. Moreover, we investigated whether EGFr-phospho-Akt and EGFr-MEK-ERK pathways can induce GBM radioresistance using inhibitors of activation of ERK (PD098059) and Akt (wortmannin). Results: At 5 Gy irradiation UGBM1 and U-87MG spheroids showed growth inhibition whereas the MO59J spheroid was relatively radioresistant. Overall, no significant changes in p53 and Hsp70 expression were found following 5 Gy irradiation treatment in all spheroids studied. The only difference observed in Hsp70 content was the periphery distribution in MO59J spheroids. However, 5 Gy treatment induced a significant increase on the EGFr levels in MO59J spheroids. Furthermore, treatment with inhibitors of activation of ERK (PD098059) and Akt (wortmannin) leads to radiosensitization of MO59J spheroids. Conclusions: These results indicate that the PI3K-Akt and MEK-ERK pathways triggered by EGFr confer GBM radioresistance.application/pdfengRadiation oncology. London. Vol. 6 (11 Nov. 2011), p. 156 [10] f.GlioblastomaProteínas de choque térmico HSP70Proteína supressora de tumor p53Esferoides celularesRadioterapiaGlioblastomaSpheroidsRadioresistanceHsp70P53Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFrEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSORIGINAL000953426.pdf000953426.pdfTexto completo (inglês)application/pdf557692http://www.lume.ufrgs.br/bitstream/10183/111830/1/000953426.pdf0c80b094b3937e06ed3c92fe2ac743beMD51TEXT000953426.pdf.txt000953426.pdf.txtExtracted Texttext/plain44063http://www.lume.ufrgs.br/bitstream/10183/111830/2/000953426.pdf.txt0004f2ab04a9d8ea081b995232fd3d21MD52THUMBNAIL000953426.pdf.jpg000953426.pdf.jpgGenerated Thumbnailimage/jpeg1941http://www.lume.ufrgs.br/bitstream/10183/111830/3/000953426.pdf.jpg1e2df8fc2ed39b12408cb1f7f1e35270MD5310183/1118302019-01-11 04:10:09.941513oai:www.lume.ufrgs.br:10183/111830Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2019-01-11T06:10:09Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr
title Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr
spellingShingle Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr
Fedrigo, Carlos Alexandre
Glioblastoma
Proteínas de choque térmico HSP70
Proteína supressora de tumor p53
Esferoides celulares
Radioterapia
Glioblastoma
Spheroids
Radioresistance
Hsp70
P53
title_short Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr
title_full Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr
title_fullStr Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr
title_full_unstemmed Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr
title_sort Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr
author Fedrigo, Carlos Alexandre
author_facet Fedrigo, Carlos Alexandre
Grivicich, Ivana
Schunemann, Daniel Pretto
Chemale, Ivan de Mello
Ferreira, Daiane Nicoli Silvello dos Santos
Jacovas, Thais
Boschetti, Patryck Stangl
Jotz, Geraldo Pereira
Braga Filho, Aroldo
Rocha, Adriana Brondani da
author_role author
author2 Grivicich, Ivana
Schunemann, Daniel Pretto
Chemale, Ivan de Mello
Ferreira, Daiane Nicoli Silvello dos Santos
Jacovas, Thais
Boschetti, Patryck Stangl
Jotz, Geraldo Pereira
Braga Filho, Aroldo
Rocha, Adriana Brondani da
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Fedrigo, Carlos Alexandre
Grivicich, Ivana
Schunemann, Daniel Pretto
Chemale, Ivan de Mello
Ferreira, Daiane Nicoli Silvello dos Santos
Jacovas, Thais
Boschetti, Patryck Stangl
Jotz, Geraldo Pereira
Braga Filho, Aroldo
Rocha, Adriana Brondani da
dc.subject.por.fl_str_mv Glioblastoma
Proteínas de choque térmico HSP70
Proteína supressora de tumor p53
Esferoides celulares
Radioterapia
topic Glioblastoma
Proteínas de choque térmico HSP70
Proteína supressora de tumor p53
Esferoides celulares
Radioterapia
Glioblastoma
Spheroids
Radioresistance
Hsp70
P53
dc.subject.eng.fl_str_mv Glioblastoma
Spheroids
Radioresistance
Hsp70
P53
description Background: Radiation therapy is routinely prescribed for high-grade malignant gliomas. However, the efficacy of this therapeutic modality is often limited by the occurrence of radioresistance, reflected as a diminished susceptibility of the irradiated cells to undergo cell death. Thus, cells have evolved an elegant system in response to ionizing radiation induced DNA damage, where p53, Hsp70 and/or EGFr may play an important role in the process. In the present study, we investigated whether the content of p53, Hsp70 and EGFr are associated to glioblastoma (GBM) cell radioresistance. Methods: Spheroids from U-87MG and MO59J cell lines as well as spheroids derived from primary culture of tumor tissue of one GBM patient (UGBM1) were irradiated (5, 10 and 20 Gy), their relative radioresistance were established and the p53, Hsp70 and EGFr contents were immunohistochemically determined. Moreover, we investigated whether EGFr-phospho-Akt and EGFr-MEK-ERK pathways can induce GBM radioresistance using inhibitors of activation of ERK (PD098059) and Akt (wortmannin). Results: At 5 Gy irradiation UGBM1 and U-87MG spheroids showed growth inhibition whereas the MO59J spheroid was relatively radioresistant. Overall, no significant changes in p53 and Hsp70 expression were found following 5 Gy irradiation treatment in all spheroids studied. The only difference observed in Hsp70 content was the periphery distribution in MO59J spheroids. However, 5 Gy treatment induced a significant increase on the EGFr levels in MO59J spheroids. Furthermore, treatment with inhibitors of activation of ERK (PD098059) and Akt (wortmannin) leads to radiosensitization of MO59J spheroids. Conclusions: These results indicate that the PI3K-Akt and MEK-ERK pathways triggered by EGFr confer GBM radioresistance.
publishDate 2011
dc.date.issued.fl_str_mv 2011
dc.date.accessioned.fl_str_mv 2015-03-07T01:57:11Z
dc.type.driver.fl_str_mv Estrangeiro
info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/111830
dc.identifier.issn.pt_BR.fl_str_mv 1748-717X
dc.identifier.nrb.pt_BR.fl_str_mv 000953426
identifier_str_mv 1748-717X
000953426
url http://hdl.handle.net/10183/111830
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Radiation oncology. London. Vol. 6 (11 Nov. 2011), p. 156 [10] f.
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/111830/1/000953426.pdf
http://www.lume.ufrgs.br/bitstream/10183/111830/2/000953426.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/111830/3/000953426.pdf.jpg
bitstream.checksum.fl_str_mv 0c80b094b3937e06ed3c92fe2ac743be
0004f2ab04a9d8ea081b995232fd3d21
1e2df8fc2ed39b12408cb1f7f1e35270
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv
_version_ 1801224866814230528